Elevance Health (ELV) Revenue — Quarter Ended Sep 30, 2023
Revenue for the quarter declined compared to the immediately preceding quarter but rose versus the same quarter one year earlier. The sequential decrease follows a period of steady growth over the prior three quarters.
Key takeaway
Quarter ended Sep 30, 2023 · FY2023 Q3
Revenue for the quarter declined compared to the immediately preceding quarter but rose versus the same quarter one year earlier. The sequential decrease follows a period of steady growth over the prior three quarters.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$42.8B
Revenue reported for this quarter.
Quarter-over-quarter
-1.9%
Change from the immediately preceding quarter.
Year-over-year
+7.3%
Change from the comparable year-ago quarter.
Trailing four quarters
$168.6B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Dec 31, 2022 | $39.9B | +9.2% |
| Mar 31, 2023 | $42.2B | +10.7% |
| Jun 30, 2023 | $43.7B | +13.0% |
| Sep 30, 2023 | $42.8B | +7.3% |
Revenue performance
The reported revenue moved lower relative to the prior quarter, breaking a streak of consecutive increases seen in earlier periods. However, on a year-over-year basis, revenue remained higher.
Quarterly comparison
Compared with the immediately preceding quarter, revenue decreased, while compared with the same quarter one year earlier, it increased. The trailing twelve-month revenue exceeded the annual total from the prior fiscal year.
What to watch
The sequential revenue change shifts from positive to negative; monitor whether this softness persists in the next quarter.